Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other 2Lymphoid 1

Conditions

Radiotherapy-induced Oral Mucositis 1Radiation-induced Oral Mucositis 1Lymphoma, Mantle-Cell 1

Interventions

Specimen Handling 602pembrolizumab 557Magnetic Resonance Spectroscopy 527Carboplatin 422Cyclophosphamide 370Cisplatin 369Biopsy 349Paclitaxel 304Gemcitabine 299Nivolumab 298Radiotherapy 256Bevacizumab 232Dexamethasone 207fludarabine 203Docetaxel 185durvalumab 177atezolizumab 172Oxaliplatin 170Fluorouracil 166venetoclax 164Rituximab 163Pemetrexed 161Doxorubicin 157Radiation 155Capecitabine 155Radiosurgery 145Etoposide 137Leucovorin 133Ipilimumab 132Lenalidomide 129

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Mouthwashes × 90 days × Clear all
NCT03623373 2026-04-21

Acalabrutinib With Bendamustine / Rituximab Followed by Cytarabine / Rituximab for Untreated Mantle Cell Lymphoma

Washington University School of Medicine

Phase 2 Completed
13 enrolled 13 charts
Lymphoid

Lymphoma, Mantle-Cell

NCT07282483 2026-03-25

Traditional Chinese Medicine Oral Liquids and Mouthwashes for Radiation-induced Oral Mucositis in Head and Neck Cancer Patients

West China Hospital

Phase 2 Recruiting
118 enrolled
Other

Radiation-induced Oral Mucositis

NCT07339774 2026-03-25

Traditional Chinese Medicine Preparation Alleviates Radiotherapy-induced Oral Mucositis in Head and Neck Cancer Patients.

West China Hospital

Phase 2 Recruiting
128 enrolled
Other

Radiotherapy-induced Oral Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡